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Abstract-During cardiac development, there is a reciprocal relationship between cardiac morphogenesis and force production (contractility). In the early embryonic myocardium, the sarcoplasmic reticulum is poorly developed, and plasma membrane calcium (Ca 2ϩ ) channels are critical for maintaining both contractility and excitability. In the present study, we identified the Ca V 3.1d mRNA expressed in embryonic day 14 (E14) mouse heart. Ca V 3.1d is a splice variant of the ␣1G, T-type Ca 2ϩ channel. Immunohistochemical localization showed expression of ␣1G Ca 2ϩ channels in E14 myocardium, and staining of isolated ventricular myocytes revealed membrane localization of the ␣1G channels. Dihydropyridine-resistant inward Ba 2ϩ or Ca 2ϩ currents were present in all fetal ventricular myocytes tested. Regardless of charge carrier, inward current inactivated with sustained depolarization and mirrored steady-state inactivation voltage dependence of the ␣1G channel expressed in human embryonic kidney-293 cells. release, which in turn regulates cardiac contractility. The L-type Ca 2ϩ channels also are an important therapeutic target for management of a variety of cardiovascular disorders. In contrast to L-type channels, T-type Ca 2ϩ channel expression and function are poorly understood, and the therapeutic potential of T-type Ca 2ϩ channels in mature myocardium is unknown. Nonetheless, earlier studies showed that de novo expression of T-type Ca 2ϩ channels may contribute to the cardiac hypertrophic phenotype. 1 More recently, Nattel and colleagues 2, 3 suggested that T-type Ca 2ϩ current might contribute to arrhythmogenesis in patients exhibiting atrial fibrillation.
L-type and T-type Ca 2ϩ channels are perhaps most clearly distinguished by their respective voltage range of activation. L-type Ca 2ϩ channels activate only with strong depolarizations (ϷϾϪ50 mV), corresponding to the plateau of the action potential. In contrast, T-type Ca 2ϩ channels activate with weak depolarizations (ϷϾϪ80 mV). In fact, we recently demonstrated that T-type Ca 2ϩ channels activate at slightly more negative potentials than even cardiac Na ϩ channel currents. 4 This low-voltage-activation range of T-type Ca 2ϩ channels allows them to provide a substantial inward, depolarizing current in the late phase of diastole. Thus it is likely that T-type Ca 2ϩ current contributes to the initiation of the action potential upstroke in pacemaker cells. [5] [6] [7] Embryonic ventricular myocytes are capable of automatic activity, in contrast to normal adult myocardium. Studies on embryonic chick ventricular myocytes clearly show the expression of T-type Ca 2ϩ current 8, 9 ; however, the literature from embryonic mouse heart is controversial. Nuss and Marbán 10 showed substantial T-type Ca 2ϩ channel expression, but Davies et al 11 were unable to detect T-type current. The recent molecular identification of T-type Ca 2ϩ channels 12,13 facilitates unequivocal detection of channel gene expression. The ␣1G channel is encoded by the Ca V 3.1 gene, 12 and there are 4 distinct splice variants in the domain III-IV connecting loop in rodents and humans. 14 -16 Our recent studies showed that mouse atrial tumor (AT-1) cells functionally express ␣1G-d (Ca V 3.1d). 17 AT-1 cells have an excitability pattern that parallels embryonic ventricular myocytes, suggesting that developing myocardium may also express ␣1G channels.
We undertook the present study to evaluate the expression of T-type Ca 2ϩ channels in embryonic myocytes. We show that the T-type Ca 2ϩ channel splice variant ␣1G-d is expressed in embryonic day 13 (E13) to E14.5 mouse ventricle, and we present data consistent with the hypothesis that Ca 2ϩ entry via the T-type channel may contribute to excitability in the developing myocardium.
Materials and Methods

Tissue Harvest
E12.5 to E13 mouse hearts were dissected free of connective tissues, and ventricles were separated from atria. For isolation of total RNA, whole ventricles were immersed in Trizol reagent (GIBCO-BRL) and homogenized. For immunohistochemistry, E13 hearts were removed, embedded in OCT compound, and rapidly frozen in a dry-ice bath. For cell isolation for patch-clamp recordings and immunocytochemistry, ventricles from 3 to 8 embryos were minced and quickly placed into nominally Ca 2ϩ -free digestion buffer containing 0.5 mg/mL collagenase (type II, Worthington) and 1 mg/mL pancreatin (GIBCO-BRL) for two 15-minute cycles.
Molecular Characterization
Total E13 ventricular RNA was characterized by reverse transcriptase-polymerase chain reaction (RT-PCR), as described elsewhere. 17
Immunostaining
Type-specific antibodies 2ϫG1 (anti-␣1G) and 2ϫH1 (anti-␣1H), prepared against peptides derived from the ␣1G and ␣1H T-type channel sequences 12, 13 (for 2ϫG1: FVCQGEDTRNITNKSD-CAEAS and 2ϫH1: YYCEGPDTRNISTKAQCRAAH), were immunoaffinity-purified commercially (Bethyl Laboratories). Monoclonal antibody MF 20 (Developmental Studies Hybridoma Bank, University of Iowa) was used to stain myofibrils using a rhodamineconjugated secondary antibody (Molecular Probes). For additional details, see the online data supplement available at http://www.circresaha.org.
Electrophysiology
Digested tissue yielded a large fraction of single, spontaneously beating cells in culture medium (DMEM with 10% FBS, 100 U/mL penicillin, and 100 mg/mL streptomycin). Cells were used within 48 hours of isolation. Cells in culture medium were rinsed with recording buffer for T-type Ca 2ϩ current (in mmol/L: CsCl 140, CaCl 2 2.5, HEPES 10, tetrodotoxin [TTX] 0.036, nifedipine 0.001, and E-4031 0.005; pH 7.4). The pipette contained 140 mmol/L CsCl, 5 mmol/L EGTA, and 5 mg ATP; pH 7.4). All recordings were at room temperature (20°C to 22°C). Mean cell capacitance was 9.1Ϯ1.6 pF, nϭ12. Additional details of recording and data analysis can be found elsewhere. 17, 18 An expanded Materials and Methods section can be found in an online data supplement available at http://www.circresaha.org.
Results
Assay of total E12 to E14 ventricular myocyte RNA by RT-PCR and DNA sequencing allows an unequivocal assessment of T-type Ca 2ϩ channel mRNA expression. We used a strategy identical to that used by Satin and Cribbs 17 to identify T-type Ca 2ϩ channels in fetal mouse ventricle. Mouse E12.5 to E14 ventricular myocytes express the ␣1G-d splice variant, as shown previously for AT-1 cells (Figure 1) . Even though the PCR primers used can amplify all 3 known T-type channels, 19 no other low-voltage-activated channels or splice variants were discovered.
The expression of mRNA does not always correlate with protein expression. To confirm protein expression, we used antibodies (2ϫG1 and 2ϫH1) to evaluate expression and localization of T-type channels in embryonic heart. Figure 2D shows a sagittal section of ventricle with vigorous staining for ␣1G. We also noted staining of vasculature and atrial walls ( Figure 2B ). Preimmune controls (Figures 2A and 2C ) and anti-␣1H antibodies did not stain (not shown). The staining of ␣1G was blocked completely by 2ϫG1 peptide-absorbed antibody ( Figure 2E ), whereas 2ϫH1 peptide had no effect on 2ϫG1 staining ( Figure 2F ). To additionally control for antibody specificity, 2ϫG1 clearly stained human embryonic kidney (HEK) cells stable-transfected with ␣1G; in contrast, HEK cells expressing ␣1H or untransfected HEK cells did not show 2ϫG1 staining (see the online data supplement). We also stained isolated ventricular myocytes using the 2ϫG1 antibody (Figure 3 ). Cells were costained with MF 20, a monoclonal antibody to myosin heavy chain, to confirm their identity as myocytes ( Figure 3A) . Figure 3B shows the expected plasma membrane localization of ␣1G, a staining pattern distinct from the myofibrillar staining with MF 20. Taken together, the RT-PCR and immunostaining results show that embryonic ventricular myocardium expresses the ␣1G-d splice variant.
We performed whole-cell mode patch-clamp recordings of embryonic ventricular myocytes to evaluate ␣1G-d channel function. To isolate T-type channel current from voltagegated Na ϩ , L-type Ca 2ϩ , and K ϩ currents, we bathed cells in Na ϩ -free bath containing 2.5 mmol/L Ba 2ϩ , 30 mol/L TTX, and 100 mol/L nifedipine. Figure 4 shows representative recordings of T-type Ca 2ϩ current. Channel kinetics ( Figure  4A ) and the steady-state inactivation voltage dependence are consistent with scoring this current as a T-type Ca 2ϩ channel current. The voltage dependence of activation is depolarizedshifted (midpointϭϪ22 mV; Figure 4B ), but this is a consistent trend observed for voltage-gated Na ϩ and Ca 2ϩ channels in developing myocardium. 8, 20 The presence of inactivating Ba 2ϩ current in 100 mol/L nifedipine ( Figures 4A and 4C ) is unequivocal evidence that the current is not through L-type Ca 2ϩ channels. We used Ni 2ϩ blockade as an indication of T-type isoform expression in fetal cardiomyocytes. Ni 2ϩ , 200 mol/L, blocks the ␣1G Ca 2ϩ channel current by Ϸ50%; in contrast, Ϸ10 mol/L Ni 2ϩ is sufficient for half-block of the ␣1H T-type Ca 2ϩ current. 21 In E12.5 to E14 ventricular myocytes, 100 mol/L Ni 2ϩ blocks T-type Ca 2ϩ current by 38.3Ϯ5.8% ( Figure 4D; nϭ3) . Ni 2ϩ -blocked and -unblocked currents have a comparable voltage dependence of inactivation consistent with a uniform dihydropyridine (DHP)-resistant channel population. On the basis of Ni 2ϩ blockade and current kinetics coupled with the molecular identification and immunohistochemical data (Figures 1 through 3) , we assign the T-type Ca 2ϩ current in embryonic ventricular myocardium as an ␣1G-d current.
Discussion
Ca V 3.1d is a splice variant of the ␣1G, T-type Ca 2ϩ channel. In this study we demonstrate for the first time, to our 
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knowledge, the following observations: (1) ␣1G mRNA and protein are expressed in developing fetal cardiac myocytes; (2) ␣1G is functionally expressed, as evidenced by T-type Ca 2ϩ currents in E12.5 to E14 ventricular myocytes; and (3) Ϸ100 mol/L Ni 2ϩ half-blocks this T-type Ca 2ϩ current. This report provides an experimental foundation for the hypothesis that T-type Ca 2ϩ current, specifically ␣1G-d, contributes to plasma membrane Ca 2ϩ flux for contraction in the developing myocardium.
Our observation that E12.5 to E14 ventricular myocytes express robust T-type Ca 2ϩ current is controversial. Nuss and Marbán 10 showed that late fetal and neonatal mouse myocytes express T-type Ca 2ϩ current (I T ), but the only other study of murine E12 to E14 ventricle detected no I T expression. 11 Recently, Leranguer et al 22 and Pignier and Potreau 23 showed progressive reduction of DHP-resistant current from postnatal day 4 through adulthood. Under conditions of millimolar extracellular Ca 2ϩ , it may be difficult to separate T-from L-type Ca 2ϩ channel current in ventricular myocytes. Nuss and Marbán 10 showed the presence of a 10 mol/L nitrendipine-resistant Ba 2ϩ current in fetal cardiomyocytes. Furthermore, this current inactivated with sustained depolarization and as a function of steady-state holding potential. Similarly, we observed a 100 mol/L nifedipine-resistant inactivating Ba 2ϩ current. Furthermore, the steady-state inactivation voltage dependence was similar to our steady-state inactivation measurements of ␣1G expressed heterologously in HEK293 cells. 4, 17 We increased the nifedipine dose to 100 mol/L to completely block L-type Ca 2ϩ current 24, 25 and exposed the cells to drug for Ͼ5 minutes to prevent confusion of use-dependent blockade of L-type channels with I T . 26 Therefore, the inward Ca 2ϩ or Ba 2ϩ current that we observe is DHP-resistant, thereby excluding L-type channels. Furthermore, the current we measure inactivates both by sustained depolarization and by steady-state holding potential; these properties exclude the unidentified current in fetal myocytes in the ␣1C knockout mouse. 27 Finally, the activity of this current in the presence of 30 mol/L TTX excludes a contribution from I Ca,TTX . 28 We also suggest that the novel fetal I Ca,fe 29 is in fact ␣1G T-type current. Given that heterologously expressed current through ␣1G is DHP resistant 30 and that kinetic and steady-state inactivation properties from fetal ventricular myocytes mirror our earlier studies of ␣1G current, we conclude that fetal ventricular myocytes express functional T-type Ca 2ϩ current. This assignment is based on a combination of the exclusion of known inward current carriers and parallels the reported properties of heterologously expressed T-type channel current.
One procedure common between the present study and the study by Nuss and Marbán 10 is that spontaneously active cells were selected for study. Automatic activity is a welldescribed property of neonatal ventricular myocytes. 31, 32 We find it interesting to note the ongoing correlation of T-type Ca 2ϩ channel expression with pacemaker cells from heart 5,6,8 and noncardiac tissues. 33 Furthermore, the ␣1G-d splice variant that we now identify in fetal ventricular myocytes is the same splice variant that we previously identified in the murine AT-1 cell line. 17 As with fetal myocytes, AT-1 cells in culture fire spontaneous action potentials. 34 Finally, our present studies and the study by Nuss and Marbán 10 corroborate earlier findings from chick that I T in early embryonic development has a depolarizing shifted voltage dependence of the macroscopic I-V curve. 8 This creates an overlap of Tand L-type Ca 2ϩ currents in the absence of DHP. In any case, our results unequivocally show that a particular splice variant of T-type Ca 2ϩ channels is expressed in E13 ventricle and is a likely pathway for inward, DHP-resistant Ca 2ϩ current. There are 3 major plasma membrane transport mechanisms for inward Ca 2ϩ flux in fetal cardiomyocytes: I Ca,L , I T , and reverse-mode Na ϩ -Ca 2ϩ exchange. Unequivocal assessment of the relative contribution of these mechanisms is hindered by the lack of selective pharmacological agents. Ni 2ϩ is relatively selective for I T compared with I Ca,L and Na ϩ -Ca 2ϩ exchange, but it may also have subtle effects, particularly on I Ca,L in the range of 100 mol/L used in this study. 35 Therefore, in the absence of selective T-type channel blockers, establishment of a role for T-type Ca 2ϩ channels in developing myocardium may ultimately require a combination of molecular genetic approaches, including their complete ablation using knockout strategies and overexpression of ␣1G-d in mouse heart.
